By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche today reported 2011 revenue growth of 6 percent at constant exchange rates for its diagnostics division including a 4 percent increase in sales for molecular diagnostic products.

The Swiss drugs, diagnostics, and research products giant reported total diagnostics sales of CHF 9.74 billion ($10.65 billion). Though the firm reported growth at constant exchange rates, in Swiss francs its diagnostics sales were down 7 percent from CHF 10.42 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.